Global PCR multiplex assays market is projected to register a healthy CAGR of 7.2% in the forecast period of 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Access Full Report at https://databridgemarketresearch.com/reports/global-pcr-multiplex-assays-market/

Drivers: Global PCR Multiplex Assays Market 

• Introduction of Novel Automated Systems
• Growing Research and Development for Drug Discovery

Restraint:

• High Cost of The Multiplex Assays

Opportunity:

• Growing Validation of Biomarkers in Molecular and Protein Diagnostics.

Challenge:

• Lack of Proficient Labor to Handle Advanced Procedures

Market Trends:

Global PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.

• On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services. In 2019, reagents & consumables segment is growing with the highest CAGR in the forecast period of 2019 to 2026.
• On the basis of application, the market is segmented into research & development and clinical diagnostics.
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.

Major Players: Global PCR Multiplex Assays Market 

Some of the major players operating in this market are Thermo Fisher Scientific Inc, Luminex Corporation, BD, QIAGEN, Agilent Technologies Inc; Meso Scale Diagnostics, LLC, Randox Laboratories Ltd., Bio-Techne, Seegene Inc., Olink, Illumina, Inc, Bio-Rad Laboratories, Inc, Abcam Plc, Quanterix, Sysmex Corporation, Siemens, F. Hoffmann-La Roche Ltd, Hologic Inc, Diasorin, Abbott, Quest Diagnostics Incorporated, PerkinElmer Inc, Eurofins Scientific, Agena Bioscience, Inc. and others.